Stockscreener 앱 받기
8.79
0.57%
-0.05
시간 외 거래:
8.79
전일 마감가:
$8.84
열려 있는:
$8.87
하루 거래량:
990.23K
Relative Volume:
1.24
시가총액:
$520.54M
수익:
$1.08B
순이익/손실:
$139.50M
주가수익비율:
3.7065
EPS:
2.3715
순현금흐름:
$205.80M
1주 성능:
-2.33%
1개월 성능:
-14.33%
6개월 성능:
-40.24%
1년 성능:
-30.40%
1일 변동 폭
$8.53
$8.87
1주일 범위
$8.47
$9.25
52주 변동 폭
$8.47
$15.55
Embecta Corp Stock (EMBC) Company Profile
명칭
Embecta Corp
전화
(862) 401-0000
주소
1209 ORANGE STREET, WILMINGTON
Compare EMBC vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EMBC
Embecta Corp
|
8.79 | 523.50M | 1.08B | 139.50M | 205.80M | 2.3715 |
ISRG
Intuitive Surgical Inc
|
464.45 | 163.73B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
156.34 | 44.73B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.51 | 36.73B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
44.00 | 36.12B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
222.85 | 32.70B | 5.40B | 1.49B | 1.78B | 10.12 |
Embecta Corp Stock (EMBC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-27 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2023-10-20 | 개시 | Wolfe Research | Peer Perform |
| 2023-01-06 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2022-09-08 | 개시 | BTIG Research | Neutral |
| 2022-08-01 | 개시 | Morgan Stanley | Equal-Weight |
| 2022-06-21 | 개시 | BofA Securities | Underperform |
모두보기
Embecta Corp 주식(EMBC)의 최신 뉴스
JPMorgan Chase & Co. Boosts Stock Position in Embecta Corp. $EMBC - MarketBeat
Embecta Corp. (NASDAQ:EMBC) Sees Large Increase in Short Interest - marketbeat.com
EMBC SEC FilingsEmbecta Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Embecta Corp. Stock Plummets to New 52-Week Low of $8.47 - Markets Mojo
Market Rankings: Why is Embecta Corp stock going upShort Setup & Risk Managed Investment Entry Signals - baoquankhu1.vn
Mills & Reeve advises Owen Mumford on £150m sale to embecta Corp in New Jersey - Business Weekly
Embecta agrees to acquire Owen Mumford - MSN
Embecta Corp. Stock Plummets to New 52-Week Low of $8.68 - Markets Mojo
Vanguard reorganizes reporting; EMBC ownership listed as 0 (EMBC) - Stock Titan
Embecta (NASDAQ:EMBC) Sets New 12-Month LowTime to Sell? - MarketBeat
Understanding the Setup: (EMBC) and Scalable Risk - news.stocktradersdaily.com
“Landmark moment” for medical device manufacturer with sale to Nasdaq-listed groupMills & Reeve advised - Insider Media Ltd
Embecta Plans Acquisition of Owen Mumford to Broaden Drug-Delivery Offerings - Bitget
Embecta to Acquire Owen Mumford to Expand Drug-Delivery Portfolio - Zacks Investment Research
Embecta to buy Owen Mumford for up to £150M - MSN
Performance Recap: Will Embecta Corp stock go up in YEAR2026 Earnings & Daily Volume Surge Signals - baoquankhu1.vn
Embecta: £150 Million Acquisition Of Owen Mumford To Expand Drug Delivery Platform Capabilities - pulse2.com
Embecta rallies after UK firm deal worth $200 million - MSN
Aug Gainers: What is the PEG ratio of Embecta Corp2026 Big Picture & AI Forecasted Stock Moves - baoquankhu1.vn
Embecta to Acquire Owen Mumford for Up to £150 Million, Expanding Drug-Delivery Device Portfolio and Global Medical Supplies Presence 123 - Minichart
Embecta to Acquire Owen Mumford in £150M Deal, Expanding Drug Delivery and Chronic Care Portfolio - Pharmacy Times
Embecta to Acquire Owen Mumford, Expanding Drug-Delivery Portfolio - tipranks.com
Embecta (NASDAQ: EMBC) to acquire Owen Mumford in up to £150m deal - Stock Titan
Embecta to acquire Owen Mumford for up to £150 million By Investing.com - in.investing.com
Embecta Corp. agreed to acquire Owen Mumford Holdings Limited from Mark Owen, Adam Mumford, Ellen Owen, Kim Priddis,Nancy Millington and others for approximately £150 million. - marketscreener.com
EmbectaAn Interesting Deal At An Interesting Time (NASDAQ:EMBC) - Seeking Alpha
Embecta to buy auto-injector maker Owen Mumford for $200M to diversify beyond insulin - Fierce Biotech
Embecta to acquire auto-injector maker Owen Mumford for up to $199.4M - drugdeliverybusiness.com
Embecta to buy Owen Mumford for up to $201M - MedTech Dive
Embecta to acquire UK medical device maker Owen Mumford for $200M - NJBIZ
Embecta (NASDAQ:EMBC) Trading 4.5% HigherTime to Buy? - MarketBeat
Embecta to Acquire Owen Mumford for up to $199.4M - mpo-mag.com
Embecta acquires Owen Mumford for £150M - BioWorld MedTech
Embecta’s $133M Acquisition of Owen Mumford Marks a Turning Point - mddionline.com
Embecta Rallies After UK Firm Deal Worth $200 Million - Benzinga
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal By Investing.com - Investing.com Australia
BTIG reiterates Embecta stock Buy rating on Owen Mumford deal - Investing.com UK
Embecta to acquire Owen Mumford - drugstorenews.com
Embecta Corp. Stock Plummets to New 52-Week Low of $8.74 - Markets Mojo
Embecta announces definitive agreement to acquire Owen Mumford Holdings Limited - marketscreener.com
Embecta to acquire Owen Mumford for up to £150 million - Investing.com
Embecta’s Purchase of Owen Mumford Establishes Q3 2026 as a Key Driver for Surpassing Earnings Expectations and Strategic Valuation Shift - Bitget
embecta Announces Definitive Agreement to Acquire Owen Mumford Holdings Limited - GlobeNewswire
Embecta Corp (EMBC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.76%
자본화:
|
볼륨(24시간):